Back
  1. Home
  3. Detailled Reference
Request a copy
Other (Scientific journals)
Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: An update from the Group for the Respect of Ethics and Excellence in Science (Osteoporosis International DOI: 10.1007/s00198-008-0670-7)
Compston, J.; Reid, D. M.; Boisdron, J. et al.
2009 • In Osteoporosis International, 20 (3), p. 497-498
Peer Reviewed verified by ORBi
Permalink
https://hdl.handle.net/2268/157329
DOI
10.1007/s00198-008-0735-7
 

Files (1)Send toDetailsStatisticsBibliographySimilar publications

Files

Full Text
Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis.pdf
Publisher postprint (46.32 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to


Details


Disciplines :
General & internal medicine
Author, co-author :
Compston, J.;  Department of Medicine, University of Cambridge, School of Clinical Medicine, Cambridge, United Kingdom
Reid, D. M.;  University of Aberdeen, Medical School, Foresterhill, Aberdeen AB25 2ZD, United Kingdom
Boisdron, J.;  Hoffman-La Roche Ltd., Basle, Switzerland
Brandi, M.-L.;  Department of Internal Medicine, Metabolic Bone Unit, University of Florence, Florence, Italy
Burlet, N.;  International Osteoporosis Foundation, Nyon, Switzerland
Cahall, D.;  Sanofi-Aventis, Bridgewater, NJ, United States
Delmas, P. D.;  Department of Medicine, University of Lyon, INSERM Research Unit 831, Lyon, France
Dere, W.;  Amgen, Thousand Oaks, CA, United States
Devogelaer, J.-P.;  Arthritis Unit, Université Catholique de Louvain, Brussels, Belgium
Fitzpatrick, L. A.;  Medicines Disease Center, GlaxoSmithKline, King of Prussia, PA, United States
Flamion, B.;  Laboratory of Physiology and Pharmacology, University of Namur, Namur, Belgium
Goel, N.;  Clinical Development, UCB Inc., Smyrna, GA, United States
Korte, S.;  Novartis Pharma, Berne, AG, Switzerland
Laslop, A.;  AGES PharmMed, Vienna, Austria
Mitlak, B.;  Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, United States
Ormarsdottir, S.;  Icelandic Medicines Control Agency, Seltjarnarnes, Iceland
Ringe, J.;  West German Osteoporosis Center (WOZ), Med. Clinic 4 at Klinikum Leverkusen, Univerity of Cologne, Cologne, Germany
Rizzoli, R.;  Department of Rehabilitation and Geriatrics, Division of Bone Diseases, Geneva University Hospitals, Geneva, Switzerland
Tsouderos, Y.;  Institut de Recherches Internationales Servier, Courbevoie, France
Van Staa, T.;  General Practice Research Database, Medicines and Healthcare Products Regulatory Agency, London, United Kingdom
REGINSTER, Jean-Yves  ;  Centre Hospitalier Universitaire de Liège - CHU > Médecine de l'appareil locomoteur
More authors (11 more) Less
Language :
English
Title :
Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: An update from the Group for the Respect of Ethics and Excellence in Science (Osteoporosis International DOI: 10.1007/s00198-008-0670-7)
Publication date :
2009
Journal title :
Osteoporosis International
ISSN :
0937-941X
eISSN :
1433-2965
Publisher :
Springer, Germany
Volume :
20
Issue :
3
Pages :
497-498
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 18 October 2013

Statistics

Number of views
67 (1 by ULiège)
Number of downloads
0 (0 by ULiège)
More statistics
Scopus citations®
 
2
Scopus citations®
without self-citations
1
OpenCitations
 
2
OpenAlex citations
 
2

Bibliography

Similar publications


Contact ORBi